Xcout Intel
FundaMental Pharma
FundaMental Pharma is a biopharmaceutical spin-off established from Heidelberg University and headquartered in Heidelberg, Germany. Its research focuses on developing novel therapeutic approaches and treatments for neurological disorders.
Subscribe to see FundaMental Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FundaMental Pharma at a glance
FundaMental Pharma is a drug discovery company headquartered in Germany. Its most recent funding round, Seed, raised $3M in April 2024. Xcout tracks 18 named people at FundaMental Pharma, including Dirk Beher (CEO).
FundaMental Pharma leadership
- Dirk BeherCEO
- Hans ErikssonChief Medical Officer
- Keno GutierrezChairman of the Board
- Hilmar BadingScientific Founder
- Alexander StraubHead of Chemistry
- Colin KahrsHead of Intellectual Property
12 more named people on record for FundaMental Pharma, with roles, board committees and tenure — see the full roster →
FundaMental Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3M | 4 named | |
| Seed | $13.8M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
FundaMental Pharma competitors
A few of FundaMental Pharma's closest competitors — see the full list of competitors and alternatives →
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Tortugas Neuroscience is a drug discovery and biopharmaceutical company headquartered in Framingham, Massachusetts. The company focuses on advancing innovative neuroscience therapeutics.
Object Pharma is a privately held biopharmaceutical company headquartered in Aliso Viejo, California, founded in 2018. The company is dedicated to developing novel treatments for mental health disorders and manufactures botulinum toxin products for accredited research use.
Neurasic Therapeutics is a Montreal-based drug discovery company founded in 2020 and based on research from McGill University's Montreal Neurological Institute. The company develops therapeutic solutions and medicinal drugs aimed at treating neurological disorders, with a primary focus on advancing opiate-sparing, pain-relieving treatments such as substituted thiophene for neuropathic and inflammatory pain.
Kupando is a pioneering Berlin-based biopharmaceutical and biotech company headquartered in Schönefeld, Germany. The company is focused on the research and clinical development of innovative treatments to fight cancer and infectious diseases.
Stellate Therapeutics is a pre-clinical stage biotechnology company that develops small molecules produced by human gut bacteria into therapies for neurodegenerative and age-related neurological diseases.
Get FundaMental Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on FundaMental Pharma in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access